Synthace Revenue and Competitors

London, UK

Location

$81M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Synthace's estimated annual revenue is currently $14.9M per year.(i)
  • Synthace's estimated revenue per employee is $155,000
  • Synthace's total funding is $81M.

Employee Data

  • Synthace has 96 Employees.(i)
  • Synthace grew their employee count by -8% last year.

Synthace's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP MarketingReveal Email/Phone
3
Head MarketingReveal Email/Phone
4
Head Research And DevelopmentReveal Email/Phone
5
Head OperationsReveal Email/Phone
6
Head Platform EngineeringReveal Email/Phone
7
Director, People and CultureReveal Email/Phone
8
Chief Scientific Officer and CofounderReveal Email/Phone
9
Chief Product OfficerReveal Email/Phone
10
Product ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.5M29-12%N/AN/A
#2
$15.7M1015%N/AN/A
#3
$87.9M40525%$292MN/A
#4
$2.6M47016%$631.7MN/A
#5
$14.9M96-8%$81MN/A
#6
$44.8M2310%$132.9MN/A
#7
$7.6M49-37%N/AN/A
#8
$17.4M11212%N/AN/A
#9
$334.6M134911%£994.6MN/A
#10
$830.2M53568%N/AN/A
Add Company

What Is Synthace?

Synthace's goal is to raise universal bioscience productivity, enabling people to better engineer biology for health, food, energy and manufacturing. Central to its technology is Antha, an operating system for biology that enables ease of designing and optimizing biological unit operations that are linked into executable workflows that are reliable, shareable and scalable. Antha spreads biological information in a repeatable way, linking lab equipment, protocols and processes, thereby allowing vast and speedy development, enhancing productivity for any bioscience. www.antha-lang.org

keywords:Biotechnology,Cleantech,Hardware,Healthcare,Pharmaceuticals,Wind Power

$81M

Total Funding

96

Number of Employees

$14.9M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Synthace News

2022-04-06 - UCL Selects Synthace to Help Make Digital, Cloud-Based Lab ...

UCL researchers will be leveraging Synthace's pioneering no-code automation R&D platform to automate routine tasks and design workflows while...

2021-11-16 - Synthace Raises $35M to Expand Access to Its Revolutionary R&D Technology for Life Changing Research

Synthace, the first life sciences software company to enable scientists to automate biology experimentation and insight sharing in a unified, global R&D environment today announced it raised $35 million in Series C funding. The investment will fuel commercial and go-to-market (GTM) growth as Syn ...

2021-11-16 - Synthace Raises $35M in Series C Funding

Synthace, a London, UK-based life sciences software company enabling scientists to automate biology experimentation and insight sharing in a unified, global R&D environment, raised $35m in Series C funding. The round was co-led by Horizons Ventures and Sofinnova Partners. The company intends t ...

2021-03-09 - Synthace Appoints Dr. Nick Jurascheck as VP of Engineering

LONDON--(BUSINESS WIRE)--Mar 9, 2021-- Synthace Ltd, the company behind Antha, the cloud-based software platform for automating and improving the success rate of biological processes, today announced the appointment of Nick Jurascheck as VP of Engineering. Dr. Jurascheck brings with him more th ...

2019-09-06 - Nanorobots Market Gaining Momentum| Cavendish Kinetics ...

... Imaging Ltd., Angstrom Advanced Inc., Zymergen, Ginkgo Bioworks, Synthace and WiTec GmbH. Global Nanorobots Market Segmentation:.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$22.5M969%N/A
#2
$25.9M963%N/A
#3
$20.2M967%N/A
#4
$24.1M962%N/A
#5
$11.5M96-14%N/A